Heterogeneity of adrenocortical ferredoxin  by Hiwatashi, Atsuo et al.
Volume 209, number 2 FEBS 4286 December 1986 
Heterogeneity of adrenocortical ferredoxin 
Atsuo Hiwatashi, Naoko Sakihama, Masateru Shin* and Yoshiyuki Ichikawa+ 
Department of Biochemistry, Kagawa Medical School, Kita-gun, Kagawa X1-07 and *Department of Biology, Faculty 
of Science, Kobe University, Nada-ku, Kobe, Hyogo 657, Japan 
Received 24 September 1986 
Bovine adrenocortical ferredoxin (adreno-ferredoxin) was purified from adrenocortical mitochondria by an 
improved method that included hydrophobic chromatography on Toyopearl gels. The purified ferredoxin 
was electrophoretically homogeneous. It was further separated into five fractions by hydrophobic chromato- 
graphy on a TSK-gel phenyl-5PW column with a high-pressure liquid chromatography system. The proper- 
ties of the three main fractions were examined. The fractions had identical absorption spectra and almost 
the same activity in an NADPH-cytochrome c reducing system. Their amino-terminal sequences all cor- 
responded to the reported sequence, but the carboxyl-terminal residues were glycine or serine, not alanine 
as reported. These results indicate that these adreno-ferredoxins had additional amino acid residues at the 
carboxyl end. It seems that adreno-ferredoxin extracted from mitochondria undergoes proteolytic attack 
during purification to become heterogeneous. 
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1. INTRODUCTION 
Adrenocortical ferredoxin (adreno-ferredoxin) 
is a protein of a low molecular mass with an iron- 
sulfur cluster of 2Fe-2S type and participates in 
electron transport from NADPH to cytochrome 
P-450 in the metabolism of steroid hormones in 
adrenocortical mitochondria. The ferredoxin was 
first noticed by Ichikawa and Yamano [1,2] as 
unusual signals at gm = 1.94 and gs = 2.01 during 
electron paramagnetic resonance (EPR) observa- 
tion of bovine adrenocortical mitochondria. The 
protein containing iron with this EPR property 
was isolated from pig adrenocortical mitochondria 
by Kimura and Suzuki [3,4] and tentatively named 
adrenodoxin. Bovine adreno-ferredoxin has been 
highly purified to a homogeneous protein with a 
molecular mass of 12 kDa, but some investigators 
have reported that bovine adrenocortical 
mitochondria have two different ferredoxins [5,6]. 
Sakihama et al. [7,8] have developed a chromato- 
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graphic method for separating two spinach fer- 
redoxins that had not been separated before in 
native form with a TSK-gel phenyl-SPW column 
by hydrophobic high-pressure liquid chromato- 
graphy (HPLC). Here we used hydrophobic 
chromatography to find whether bovine adreno- 
ferredoxin also contains more than one com- 
ponent .
2. MATERIALS AND METHODS 
2.1. Purification of bovine adreno-ferredoxin 
Bovine adrenal glands were obtained from a 
local slaughterhouse and adrenocortical mitochon- 
dria were prepared from them by a method 
reported elsewhere [9]. The purification of adreno- 
ferredoxin from the mitochondria was improved 
by the introduction of hydrophobic column 
chromatography with Toyopearl HW-65C and 
butyl-Toyopearl 650M according to the purifica- 
tion method for plant ferredoxins [lo]. The 
method included the following purification steps: 
i, extraction by sonication from the mitochondria; 
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ii, batch-wise adsorption with DEAE-cellulose; iii, 
removal of impure proteins by ammonium sulfate 
precipitation at 60% saturation; and iv, 
hydrophobic chromatography with Toyopearl 
HW-6% and butyl-Toyopearl 650M columns. 
Details will be reported elsewhere. 
2.2. Separation of the purified adreno-ferredoxin 
by HPLC with a phenyl-SPW column 
Analytical hydrophobic chromatography of the 
purified adreno-ferredoxin was done on a TSK-gel 
phenyl-5PW column (0.75 x 7.5 cm) with a Toyo 
Soda HLC-CCPM HPLC system following the 
method of Sakihama et al. [7]. For preparation, 
the ferredoxin was separated on a large 
phenyl-5PW column (2.2 x 15 cm) equilibrated 
with 20 mM Tris-HCl buffer, pH 7.5, containing 
1.6 M ammonium sulfate with the same buffer 
containing 1.45 M ammonium sulfate. Phenyl- 
5PW columns were obtained from the Toyo Soda 
Manufacturing Co. 
2.3. Assay of enzymatic activity 
The enzymatic activity of adreno-ferredoxin was 
assayed in an NADPH-cytochrome c reducing 
system [9]. 
2.4. Amino acid analysis 
Amino acid analysis was done on an automated 
amino acid analyzer (Hitachi model 835) using the 
method of Spackman et al. [ 111. The amino acid 
sequence was obtained with an Applied Biosystems 
sequencer (model 470A) according to Laursen [ 121. 
The carboxyl-terminal amino acid was identified 
by hydrazinolysis as in [ 13,141. 
3. RESULTS AND DISCUSSION 
Bovine adreno-ferredoxin was purified more 
easily by the improved method of hydrophobic 
chromatography with Toyopearl gels than by the 
conventional method. The highly purified prepara- 
tion migrated as a single band on SDS- 
polyacrylamide gel electrophoresis and had an ab- 
sorbance ratio, Aqi4/&0, of 0.9, the highest puri- 
ty reported so far [ 151. Its molecular mass was 
estimated to be 14 kDa by SDS-polyacrylamide gel 
electrophoresis and 13 kDa by gel filtration HPLC 
on a TSK-gel G3000SW column. These observa- 
tions confirmed that the highly purified prepara- 
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tion was homogeneous in monomeric form. 
However, the preparation was further separated 
into five fractions by hydrophobic HPLC with a 
phenyl-5PW column (fig.1). The five fractions of 
adreno-ferredoxin already existed in the crude 
preparation obtained after the batch-wise adsorp- 
tion step in this purification (fig.%). Fig.2 also 
shows that the elution profile of the five fractions 
changed during incubation at room temperature 
(20”(Z), suggesting that adreno-ferredoxin was at- 
tacked by proteolytic enzymes during purification. 
To investigate properties of the individual frac- 
tions, we rapidly purified adreno-ferredoxin and 
immediately separated the fractions using a 
preparative phenyl-5PW column. Fractions III, IV 
and V were obtained in sufficient amounts, but 
fractions I and II were not. We therefore studied 
only the three main fractions extensively. They had 
identical absorption spectra; that of fraction V is 
shown in fig.3. No large difference in electron 
transport activity in an NADPH-cytochrome c 
reducing system [9] was found between them. The 
fractions migrated as a single band on SDS- 
polyacrylamide gel electrophoresis, where their 
molecular mass was estimated to be 14 kDa. This 
value was slightly larger than that reported 
elsewhere (12-13 kDa; [16,17]). Tanaka et al. [18] 
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Fig.1. Separation of highly purified bovine adreno- 
ferredoxin by hydrophobic HPLC. 1Opg of adreno- 
ferredoxin was loaded on a TSK-gel phenyl-SPW 
column (0.75 x 7.5 cm) equilibrated with 20 mM Tris- 
HCl buffer, pH 7.5, containing 2 M ammonium sulfate 
and eluted with a 40-min linear gradient of ammonium 
sulfate (2-l M) at a flow rate of 1 ml/min. Adreno- 
ferredoxin was detected by measurement of absorbance 
at 414 nm. 
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Fig.2. Detection of adreno-ferredoxin fractions in a 
crude preparation by hydrophobic HPLC. The crude 
adreno-ferredoxin preparation that was freshly prepared 
was incubated at 20°C for the indicated number of hours 
and analyzed by hydrophobic HPLC as in fig. 1, except 
that a 20-min linear gradient of ammonium sulfate 
(1.5-l M) was used. 
reported that bovine adreno-ferredoxin has 114 
amino acid residues including 18 Asx, 7 Ser, 11 
Glx, 8 Gly, 3 Met, 8 Ile, 6 Lys and 5 Arg, with a 
molecular mass of 12.5 kDa. According to 
Okamura et al. [19] it contains 128 amino acid 
residues including 20 Asx, 10 Ser, 13 Glx, 9 Gly, 5 
Met, 10 Ile, 6 Lys, and 5 Arg, with a molecular 
mass of 14 kDa. This group deduced the primary 
structure of bovine adreno-ferredoxin by 
nucleotide sequencing of the protein gene and 
found an additional peptide at the carboxyl-end, 
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Fig.3. The optical absorption spectrum of adreno- 
ferredoxin fraction V in the oxidized form. The 
spectrum was recorded in 20 mM Tris-HCI buffer, pH 
7.4, with a Shimadzu spectrophotometer (model 
uv-240). 
which was composed of 14 amino acid residues, 2 
Asx, 3 Ser, 2 Glx, 1 Gly, 2 Met, 2 Ile, 1 Lys, and 
1 Arg (fig.4). The amino acid compositions of our 
adreno-ferredoxins are shown in table 1. They 
have 20 Asx, 7-10 Ser, 13 Glx, 10 Gly, 4-5 Met, 
8-9 Ile, 5 Lys, and 5 Arg in 123-126 residues on 
the basis of a molecular mass of 14 kDa. Their 
amino-terminal sequences were identified up to 18 
cycles. They all had the same sequence of NHz-Ser- 
Ser-Ser-Glu-Asp-Lys-Ile-Thr-Val-His-Phe-Ile-Asn- 
Arg-Asp-Gly-Glu-Thr-, which was the same as that 
reported by Okamura et al. [19]. The carboxyl- 
terminal amino acids of fractions III and IV were 
found to be glycine and serine, respectively, rather 
114 120 128 
Okamura et al. ---Asp-Ala-Arg-Glu-Ser-Ile-Asp-Met-Gly-Met-Asn-Ser-Ser-Lys-Ile-Glu-COOH 
Tanaka et aZ. ---Asp-Ala-COOH 
Fraction IU ---Asp-Ala-Arg-Glu-Ser-Ile-Asp-Met-Gly-COOH 
Fraction IV ---Asp-Ala-Arg-Glu-Ser-Ile-Asp-Met-Gly-Met-Asn-Ser-COOH 
Fraction Va) ---Asp-Ala-Arg-Glu-Ser-Ile-Asp-Met-Gly-Met-Asn-Ser-Ser-COOH 
a) Main component of Fraction V. 
Fig.4. Proposed carboxyl-terminal sequences of bovine adreno-ferredoxin fractions. 
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Table 1 
Amino acid compositions of bovine adreno-ferredoxin fractions 
December 1986 
Amino 
acids 
Highly 
purified 
prep. III 
Fractions Tanaka Okamura 
et al.a et alb 
IV V 
Asx 
Thr 
Ser 
Glx 
Pro 
ClY 
Ala 
Val 
Met 
Be 
Leu 
Tyr 
Phe 
Lys 
His 
Trp 
Arg 
Cys 
Total 
20.47 20.72 
8.95 9.59 
6.63 7.74 
13.91 13.55 
1.38 0.88 
10.13 9.94 
7.28 7.52 
7.00 6.82 
4.80 4.57 
8.54 8.71 
12.73 12.67 
1.09 1.01 
4.07 4.40 
5.69 5.28 
3.09 3.12 
0.0 0.0 
6.10 5.85 
21.19 
9.37 
7.13 
13.05 
0.65 
9.98 
7.53 
6.87 
5.08 
8.80 
12.74 
1.00 
4.38 
5.25 
3.62 
0.0 
5.82 
(%) 
(21 .O) 
(10.2) 
(10.0) 
(13.1) 
(1.2) 
(10.2) 
(7.8) 
(6.2) 
(5.2) 
(8.6) 
(12.8) 
(0.9) 
(4.0) 
(5.2) 
(3.0) 
(n.d.) 
(5.4) 
(n.d.) 
(126) 
20.65 
9.52 
8.53 
13.29 
0.90 
10.34 
7.49 
6.71 
4.84 
8.70 
12.38 
0.99 
4.33 
5.10 
3.16 
0.0 
5.67 
(Z) 
(21 .O) 
(10.0) 
(9.8) 
(13.2) 
(2.6) 
(10.2) 
(7.3) 
(5.8) 
(5.0) 
(8.2) 
(12.2) 
(0.8) 
(3.2) 
(4.9) 
(2.8) 
(n.d.) 
(5.4) 
(n.d.) 
(126) 
18 20 
10 10 
I 10 
11 13 
1 1 
8 9 
7 7 
7 7 
3 5 
8 10 
12 12 
1 1 
4 4 
5 6 
3 3 
0 0 
4 5 
(11:) (12:) 
a By protein sequencing [ 181 
b By nucleotide sequencing [19] 
Calculated after 24 h hydrolysis based on a molecular mass of 14 kDa without an iron-sulfur cluster. The 
value in parentheses was determined by extrapolation of amino acid analysis data after 12, 24 and 48 h 
hydrolysis 
than the alanine reported by Tanaka et al. [ 181. 
The carboxyl-terminal amino acid of fraction V 
was mainly serine and glycine was also found as 
contaminant. 
Our highly purified adreno-ferredoxin prepara- 
tion was a mixture of fractions with different 
carboxyl-terminal ends. The probable carboxyl- 
terminal structure of the three fractions is given in 
fig.4. The structures were longer than that found 
by Tanaka’s group with Ala-114 and shorter than 
that found by Okamura’s with Glu-128. Okamura 
et al. [19] proposed that the elongated peptide 
might be a precursor segment o be processed ur- 
ing the importation of pro-adreno-ferredoxin into 
adrenocortical mitochondria. However, our 
adreno-ferredoxin retained a part of the precursor 
segment. The main component of fraction V is the 
longest and only three amino acid residues were 
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lacking from that reported by Okamura’s group. 
Since fraction V in the crude preparation decreased 
during incubation while fractions III and IV in- 
creased (fig.2), fractions III and IV were probably 
derived from the main component of fraction V by 
proteolytic attack during purification. We have no 
evidence that fraction V is the intact structure of 
adreno-ferredoxin that is present in adrenocortical 
mitochondria. 
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